|
| |
| | | 57466 | | 03.11.2005 | | Novartis Pharma Schweiz AG | | 19.10.2007 | | | | | | | | | | | 06.99. | | | | 06.99. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Exjade 125 mg | dispergierbare Tabletten | Dispersible Tabletten (Deferasirox 125 mg) | V03AC03 | PI | | 02 | Exjade 250 mg | dispergierbare Tabletten | Dispersible Tabletten (Deferasirox 250 mg) | V03AC03 | PI | | 03 | Exjade 500 mg | dispergierbare Tabletten | Dispersible Tabletten (Deferasirox 500 mg) | V03AC03 | PI |
|
|
|
